The over-arching objectives of the Neuromedical Core (NMC) are to provide comprehensive clinical and? laboratory evaluations, scientific consultation, and mentorship, training, and community education in? NeuroAIDS. In the current funding period the NMC facilitated 79 research projects including observational? cohort studies, clinical-pathological investigations, imaging studies, clinical trials and international research? performed by collaborating investigators at UCSD and many other institutions. The HNRC's collaborating? investigators find data generated by the NMC, including neurological diagnostic formulations, antiretroviral? (ARV) treatment information, HIV disease staging information, viral loads and a variety of other clinical? laboratory measurements, to be essential for their data analyses and publications.? Recognizing that maintaining vitality and scientific relevance necessitates continual adaptation to the? changing needs of the HNRC research enterprise and the scientific agendas of its many principal? investigators and collaborators, we propose to enhance the NMC in this renewal in two ways. First, we will? add a pharmacology component that will focus on ARV drug penetration into the CMS. Second, we will? incorporate functions previously carried out by the Cellular Immunology and Fluids Core. The newly-organized? NMC is made up of three cooperative units, each comprising common resources (equipment,? supplies) and staff that interact on a daily basis: a Clinical Unit; a Patient-Derived Sample Unit; and a? Pharmacology & Biomarker Unit. Examples of scientific questions the Core will facilitate answering are? 1) What is the contributory role in neuroAIDS of co-pathogens and comorbidities such as hepatitis C virus? (HCV) and substance abuse? 2) Does cerebrospinal fluid (CSF) provide a useful window to evaluate? virus-host interactions and molecular pathogenesis in neuroAIDS? 3) What is the role of the CNS in viral? evolution, adaptation and the occurrence of ARV drug resistance? 4) How do host genetics influence HIV? neuropathogenesis?? By assisting investigators in widely diverging disciplines at all levels of project development, from? conceptualization of hypotheses to study implementation, analysis, interpretation and dissemination, the? NMC encourages the application of multiple scientific perspectives and stimulates interdisciplinary? collaboration and coordination. We will collaborate closely with the Neuroimaging, Neurobehavioral,? Neurovirology and Neurobiology Cores to further stimulate transdisciplinary aims. In addition to supporting? the performance of research research, the NMC also enhances and extends the effectiveness and public? health impact of new findings related to mental health and HIV/AIDS.?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
5P30MH062512-08
Application #
7585177
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
8
Fiscal Year
2008
Total Cost
$421,506
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Walker, Rheeda L; Hong, Judy H; Talavera, David C et al. (2018) Health literacy and current CD4 cell count in a multiethnic U.S. sample of adults living with HIV infection. Int J STD AIDS 29:498-504
Heldt, Sven; Prattes, Juergen; Eigl, Susanne et al. (2018) Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect 77:235-241
Jenks, Jeffrey Daniel; Hoenigl, Martin (2018) CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy. J Lab Precis Med 3:
Ocque, Andrew J; Hagler, Colleen E; Morse, Gene D et al. (2018) Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid. J Pharm Biomed Anal 156:163-169
Soontornniyomkij, Virawudh; Umlauf, Anya; Soontornniyomkij, Benchawanna et al. (2018) Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS 32:2005-2015
Moore, Raeanne C; Hussain, Mariam A; Watson, Caitlin W-M et al. (2018) Grit and Ambition are Associated with Better Neurocognitive and Everyday Functioning Among Adults Living with HIV. AIDS Behav 22:3214-3225
Patel, Atul K; Patel, Ketan K; Gohel, Swati et al. (2018) Incidence of symptomatic CSF viral escape in HIV infected patients receiving atazanavir/ritonavir (ATV/r)-containing ART: a tertiary care cohort in western India. J Neurovirol 24:498-505
Kanmogne, Georgette D; Fonsah, Julius Y; Tang, Bin et al. (2018) Effects of HIV on executive function and verbal fluency in Cameroon. Sci Rep 8:17794
Kabuba, Norma; Menon, J Anitha; Franklin, Donald R et al. (2018) Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults. Neuropsychology 32:519-528
Gianella, Sara; Marconi, Vincent C; Berzins, Baiba et al. (2018) Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. J Acquir Immune Defic Syndr 79:e112-e114

Showing the most recent 10 out of 743 publications